跳至主要内容
临床试验/IRCT20130829014521N18
IRCT20130829014521N18尚未招募2 期

Investigation of the effects of oral trehalose supplementation on glycemic control in patients with type 2 diabetes

ational Institute for Medical Research Development0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 85 years(—)
性别
All

入选标准

  • Male or female patients aged between 35 and 85 years
  • Patients with non-insulin-dependent diabetes mellitus in a stable condition.

排除标准

  • Patients with type 1, type 2, or secondary diabetes receiving insulin therapy.
  • Patients with renal dysfunction (eGFR less than 30 ml/min).
  • Patients with severe liver dysfunction or cirrhosis.
  • Patients regularly receiving oral or injectable corticosteroids.
  • Patients who were pregnant or nursing or wished to conceive.
  • Patients participating in this study will be excluded from the study if they need insulin.
  • Patients who used a-Glucosidase Inhibitors such as acarbose will be excluded from the study.

研究者

发起方
ational Institute for Medical Research Development

相似试验